We are live on !
Find out more
RS
R Squared Portfolio holdings
AUM
$190M
Turnover
64%
1-Year Est. Return
25.89%
This Fund
S&P 500
This Quarter Est. Return
+15.51%
1 Year Est. Return
+25.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$190M
AUM Growth
+$8.35M
(+4.6%)
Cap. Flow
-$4.65M
Cap. Flow % of AUM
Cap. Flow %
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
14.08%
Holding
725
New
248
Increased
120
Reduced
140
Closed
216
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.2
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.3M |
| 2 |
Penumbra
PEN
|
+$2.89M |
| 3 |
Intuitive Surgical
ISRG
|
+$1.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.71M |
| 5 |
Costco
COST
|
+$1.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$5.96M |
| 2 |
Apple
AAPL
|
+$3.04M |
| 3 |
Micron Technology
MU
|
+$2.56M |
| 4 |
Eli Lilly
LLY
|
+$2.13M |
| 5 |
Visa
V
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.35% |
| 2 | Technology | 17.3% |
| 3 | Industrials | 15.96% |
| 4 | Healthcare | 11.59% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
GSK
GSK
$100B
| $275K | 0.14% |
5,244
+1,088
| +26% | +$57.5K |
2025 Q4
2 quarters
|
|
252
Victoria's Secret
VSXY
$7.13B
| $273K | 0.14% |
+3,276
| New | +$196K |
2026 Q2
0 quarters
|
|
253
Phoenix Education Partners
PXED
$845M
| $273K | 0.14% |
8,315
-1,223
| -13% | -$36.5K |
2026 Q1
1 quarter
|
|
254
Akamai
AKAM
$12.9B
| $273K | 0.14% |
+2,309
| New | +$287K |
2026 Q2
0 quarters
|
|
255
Comfort Systems
FIX
$49.5B
| $272K | 0.14% |
137
-228
| -62% | -$414K |
2024 Q4
6 quarters
|
|
256
CoStar Group
CSGP
$13.3B
| $271K | 0.14% |
+9,562
| New | +$329K |
2026 Q2
0 quarters
|
|
257
LeMaitre Vascular
LMAT
$1.9B
| $270K | 0.14% |
2,817
+246
| +10% | +$25.2K |
2025 Q3
3 quarters
|
|
258
Amarin Corp
AMRN
$244M
| $270K | 0.14% |
+16,938
| New | +$250K |
2026 Q2
0 quarters
|
|
259
BOK Financial
BOKF
$7.66B
| $268K | 0.14% |
+1,927
| New | +$255K |
2026 Q2
0 quarters
|
|
260
Center Bancorp
CNOB
$1.54B
| $267K | 0.14% |
+7,976
| New | +$239K |
2026 Q2
0 quarters
|
|
261
V2X
VVX
$2.21B
| $266K | 0.14% |
+3,568
| New | +$265K |
2026 Q2
0 quarters
|
|
262
Plug Power
PLUG
$1.97B
| $265K | 0.14% |
97,960
-20,139
| -17% | -$63.3K |
2025 Q2
4 quarters
|
|
263
NRC Health Common Stock
NRC
$446M
| $265K | 0.14% |
+12,288
| New | +$228K |
2026 Q2
0 quarters
|
|
264
WESCO International
WCC
$17B
| $265K | 0.14% |
+767
| New | +$260K |
2026 Q2
0 quarters
|
|
265
Metropolitan Bank Holding Corp
MCB
$1.12B
| $264K | 0.14% |
2,674
-460
| -15% | -$41.7K |
2026 Q1
1 quarter
|
|
266
OrthoPediatrics
KIDS
$613M
| $264K | 0.14% |
13,800
+448
| +3% | +$7.79K |
2026 Q1
1 quarter
|
|
267
NuScale Power
SMR
$2.25B
| $261K | 0.14% |
26,019
+11,733
| +82% | +$132K |
2025 Q2
4 quarters
|
|
268
Provident Financial Services
PFS
$2.92B
| $261K | 0.14% |
+11,037
| New | +$248K |
2026 Q2
0 quarters
|
|
269
Cemex
CX
$15B
| $261K | 0.14% |
21,734
-3,529
| -14% | -$43.8K |
2025 Q4
2 quarters
|
|
270
BitMine Immersion Technologies
BMNR
$14.5B
| $261K | 0.14% |
19,582
+4,279
| +28% | +$82.7K |
2026 Q1
1 quarter
|
|
271
Restaurant Brands International
QSR
$25.8B
| $261K | 0.14% |
+3,593
| New | +$274K |
2026 Q2
0 quarters
|
|
272
Gold Fields
GFI
$32.4B
| $260K | 0.14% |
+7,755
| New | +$323K |
2026 Q2
0 quarters
|
|
273
ICICI Bank
IBN
$105B
| $260K | 0.14% |
8,954
-7,878
| -47% | -$213K |
2025 Q2
4 quarters
|
|
274
Intellia Therapeutics
NTLA
$1.63B
| $258K | 0.14% |
+15,246
| New | +$213K |
2026 Q2
0 quarters
|
|
275
Emcor
EME
$30.8B
| $257K | 0.14% |
+310
| New | +$262K |
2026 Q2
0 quarters
|
|
Similar funds
EL
R Squared's Q2 2026 Portfolio in Review
As of Q2 2026, R Squared held 725 positions worth $190M, up 4.6% from $182M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
R Squared's Q2 2026 filing shows 248 new, 120 increased, 140 reduced and 216 closed positions. Its largest new stake was Meta Platforms (Facebook): 2,795 shares worth $1.57M. The largest sale was Hologic, an estimated $5.96M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- R Squared's largest Q2 2026 buy was Meta Platforms (Facebook): 2,795 shares worth $1.57M.
- R Squared added most to NVIDIA in Q2 2026, an estimated $3.3M increase.
- R Squared's biggest Q2 2026 reduction was Apple, cutting an estimated $3.04M.
- R Squared fully exited Hologic in Q2 2026, selling an estimated $5.96M.
- R Squared's ten largest holdings make up 14% of its $190M portfolio in Q2 2026.
- R Squared opened 248 new positions and closed 216 in Q2 2026.
- R Squared's portfolio value rose 4.6% quarter-over-quarter to $190M.
Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.